Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Cherington Insider Profile
11 Followers
Charles Cherington, Ten Percent Owner at Eterna Therapeutics, holds 16.63M shares in Eterna Therapeutics (Ticker: ERNA), holds 7.37M shares in Comera Life Sciences Holdings (Ticker: CMRA). Most recently, Charles Cherington Bought ― shares of Eterna Therapeutics on Nov 05, 2024 for an estimated value of 1.37M.
Charles Cherington Eterna Therapeutics (ERNA)Ten Percent Owner
Eterna Therapeutics (ERNA)
Ten Percent Owner
Ranked #97,157 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 10 Profitable Transactions
Average Return
-64.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Charles Cherington holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 21, 2021 - Jun 21, 2022
Return:+97.00%
The most profitable trade made by Charles Cherington
Charles Cherington's Trading History
Eterna Therapeutics
Nov 05, 2024
Ten Percent Owner
Informative Buy
1.37M
$4.16M
Comera Life Sciences Holdings
Sep 11, 2023
Ten Percent Owner
Informative Buy
1.05M
$73.68K
List of latest transactions for each holding click on a transaction to see Charles Cherington's performance on stock
You May Also Like
Charles Cherington insider profile FAQ
What is the percentage of profitable transactions made by Charles Cherington?
The percentage of profitable transactions made by Charles Cherington is 10%.
What is the average return per transaction made by Charles Cherington?
The average return per transaction made by Charles Cherington is -64.50%.
What stocks does Charles Cherington hold?
Charles Cherington holds: ERNA, CMRA stocks.
What was Charles Cherington’s latest transaction?
Charles Cherington latest transaction was an Informative Buy of $1.37M.
What was Charles Cherington's most profitable transaction?
Charles Cherington’s most profitable transaction was an Informative Sell of ERNA stock on June 21, 2021. The return on the trade was 97.00%.
What is Charles Cherington's role in Eterna Therapeutics?
Charles Cherington's role in Eterna Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.